Harbin Pharmaceutical Group Holding Company
1989
FOUNDED
PUBLIC
STATUS
1K-5K
EMPLOYEES
600829
STOCK SYMBOL
3
INVESTMENTS
$1.18
SHARE PRICE
(As of Friday Closing)
Description
HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engaged in the production and sale of pharmaceuticals products in China.
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Distributors/Wholesale
Stock Exchange
SHG
Primary Office
- Number 109 Xue Fu Road
- Harbin City, Nangang District 150086
- China
+86 0451 0000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Harbin Pharmaceutical Group Holding Company’s full profile, request a free trial.
Harbin Pharmaceutical Group Holding Company Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $0.70 - $1.50 | $682M | $1.15 | $0.07 | 5.82M | 580M |
Harbin Pharmaceutical Group Holding Company Financials Summary
|
In Thousands,
USD |
TTM
30-Jun-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 598,418 | 482,248 | 1,069,813 | 1,245,202 |
| Revenue | 1,104,387 | 1,066,504 | 1,185,105 | 1,352,018 |
| EBITDA | 57,582 | 59,618 | 57,293 | 50,592 |
| Net Income | 38,723 | 38,979 | 37,614 | 33,706 |
| Total Assets | 676,721 | 641,424 | 741,557 | 692,716 |
| Total Debt | 57,209 | 32,563 | 34,310 | 15,841 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Harbin Pharmaceutical Group Holding Company Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Harbin Pharmaceutical Group Holding Company‘s full profile, request access.
Request full access to PitchBookHarbin Pharmaceutical Group Holding Company Investments & Acquisitions (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 000000 000 | 13-Feb-2018 | 00000 0000000 | Distributors/Wholesale | ||
| 0000000 000000000 | 13-Feb-2018 | 0000 | 00000 | Specialty Retail | 00000 00000 |
| Pfizer(swine vaccine business) | 31-May-2010 | Merger/Acquisition | 0000 | Drug Delivery |
Harbin Pharmaceutical Group Holding Company Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Harbin Pharmaceutical Group Holding Company‘s full profile, request access.
Request full access to PitchBookHarbin Pharmaceutical Group Holding Company Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Lijun Zhang | Chairman & General Manager | ||
| Chang Sun | Director |
Harbin Pharmaceutical Group Holding Company Board Members (1)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 00000 00000 | Harbin Pharmaceutical Group Holding Company | Chairman & General Manager | 000 0000 |